WIM
ETON icon

Westside Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Westside Investment Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Sell
431,160
-36,755
-8% -$1.08M 2.05% 7
2026
Q1 		$11.5M Sell
467,915
-3,025
-0.6% -$52.9K 1.77% 8
2025
Q4 		$7.96M Sell
470,940
-1,600
-0.3% -$28.2K 1.27% 19
2025
Q3 		$10.3M Sell
472,540
-250
-0.1% -$4.15K 1.64% 11
2025
Q2 		$6.74M Sell
472,790
-20,860
-4% -$330K 1.25% 16
2025
Q1 		$6.41M Sell
493,650
-81,572
-14% -$1.23M 1.36% 13
2024
Q4 		$7.66M Sell
575,222
-43,453
-7% -$441K 1.61% 12
2024
Q3 		$3.71M Buy
618,675
+33,275
+6% +$141K 0.79% 32
2024
Q2 		$1.93M Buy
585,400
+11,440
+2% +$40K 0.44% 56
2024
Q1 		$2.15M Buy
573,960
+10,850
+2% +$47.4K 0.52% 48
2023
Q4 		$2.47M Buy
563,110
+34,800
+7% +$140K 0.63% 37
2023
Q3 		$2.2M Buy
528,310
+9,059
+2% +$35K 0.63% 39
2023
Q2 		$1.81M Buy
519,251
+1,950
+0.4% +$7.17K 0.51% 51
2023
Q1 		$1.99M Sell
517,301
-36,900
-7% -$135K 0.58% 44
2022
Q4 		$3.01K Buy
554,201
+81,850
+17% +$220K 0.01% 223
2022
Q3 		$2.04K Buy
472,351
+126,801
+37% +$316K ﹤0.01% 241
2022
Q2 		$3.06K Buy
345,550
+103,330
+43% +$347K 0.01% 228
2022
Q1 		$3.21K Buy
242,220
+123,695
+104% +$487K 0.01% 228
2021
Q4 		$3.03K Buy
118,525
+13,225
+13% +$63.3K 0.01% 219
2021
Q3 		$3.05K Buy
105,300
+3,500
+3% +$18.2K 0.01% 217
2021
Q2 		$3.7K Buy
101,800
+15,275
+18% +$113K 0.01% 208
2021
Q1 		$4.29K Buy
86,525
+2,625
+3% +$22.4K 0.01% 196
2020
Q4 		$4.74K Buy
83,900
+850
+1% +$6.56K 0.01% 156
2020
Q3 		$4.6K Buy
83,050
+1,000
+1% +$6.83K ﹤0.01% 163
2020
Q2 		$3.17K Buy
82,050
+34,300
+72% +$170K ﹤0.01% 151
2020
Q1 		$195 Buy
+47,750
New +$279K ﹤0.01% 236

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LK
Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Westside Investment Management's ETON Position: Q2 2026 in Review

Westside Investment Management reduced its Eton Pharmaceutcials (ETON) stake by 7.9% in Q2 2026, selling an estimated $1.08M and leaving 431,160 shares worth $15.6M. The position accounts for 2.05% of the portfolio, ranked #7.

Westside Investment Management first reported a position in ETON in Q1 2020 and has held it in 26 quarters since. 58 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Westside Investment Management held 431,160 shares of Eton Pharmaceutcials worth $15.6M as of Q2 2026.
  • Westside Investment Management sold 36,755 Eton Pharmaceutcials shares in Q2 2026, an estimated $1.08M.
  • Eton Pharmaceutcials made up 2.05% of Westside Investment Management's portfolio in Q2 2026, its #7 holding.
  • Westside Investment Management first reported a position in Eton Pharmaceutcials in Q1 2020 and has held it in 26 quarters since.
  • 58 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.